These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35819584)

  • 1. Experiences of individuals with a variant of uncertain significance on genetic testing for hereditary cancer risks: a mixed method systematic review.
    Gould D; Walker R; Makari-Judson G; Seven M
    J Community Genet; 2022 Aug; 13(4):371-379. PubMed ID: 35819584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics.
    Menke C; Nagaraj CB; Dawson B; He H; Tawde S; Wakefield EG
    J Genet Couns; 2021 Dec; 30(6):1559-1569. PubMed ID: 33969574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.
    Cragun D; Dean M; Baker D; Kelley M; Hooker G; Weidner A; Hunt P; Pal T
    Curr Oncol; 2024 Jun; 31(6):3361-3378. PubMed ID: 38920739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
    Reuter C; Chun N; Pariani M; Hanson-Kahn A
    J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of patients seeking to participate in variant of uncertain significance reclassification research.
    Makhnoon S; Garrett LT; Burke W; Bowen DJ; Shirts BH
    J Community Genet; 2019 Apr; 10(2):189-196. PubMed ID: 30027524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
    Solomon I; Harrington E; Hooker G; Erby L; Axilbund J; Hampel H; Semotiuk K; Blanco A; Klein WMP; Giardiello F; Leonard L
    J Genet Couns; 2017 Aug; 26(4):866-877. PubMed ID: 28127677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer patients' experience of receiving variant of uncertain significance results: An Asian perspective.
    Ishak ND; Shaw T; Li ST; Yuen J; Goh HX; Chua ZY; Suresh P; Que FVF; Zhang Z; Chiang J; Ngeow J
    J Genet Couns; 2024 Oct; 33(5):985-994. PubMed ID: 37864575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives.
    Abdel-Razeq H; Tamimi F; Abujamous L; Abdel-Razeq R; Abunasser M; Edaily S; Abdulelah H; Khashabeh RA; Bater R
    Front Oncol; 2022; 12():673094. PubMed ID: 35402282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.
    Underhill-Blazey M; Blonquist T; Chittenden A; Pozzar R; Nayak M; Lansang K; Hong F; Garber J; Stopfer JE
    J Genet Couns; 2021 Feb; 30(1):268-282. PubMed ID: 32851753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring relatives' perceptions of participation, ethics, and communication in a patient-driven study for hereditary cancer variant reclassification.
    Tsai GJ; Chen AT; Garrett LT; Burke W; Bowen DJ; Shirts BH
    J Genet Couns; 2020 Oct; 29(5):857-866. PubMed ID: 31916645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
    Chang J; Seng S; Yoo J; Equivel P; Lum SS
    Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes.
    Miller IM; Lewis KL; Lawal TA; Ng D; Johnston JJ; Biesecker BB; Biesecker LG
    Genet Med; 2019 Mar; 21(3):748-752. PubMed ID: 29997389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
    Kwong A; Ho CYS; Shin VY; Au CH; Chan TL; Ma ESK
    BMC Med Genomics; 2022 May; 15(1):122. PubMed ID: 35641994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer patients' understandings of genetic variants of uncertain significance in clinical care.
    Amano Y; Raz A; Timmermans S; Shkedi-Rafid S
    J Community Genet; 2022 Aug; 13(4):381-388. PubMed ID: 35616809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.
    MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
    Medendorp NM; van Maarschalkerweerd PEA; Murugesu L; Daams JG; Smets EMA; Hillen MA
    Patient Educ Couns; 2020 Sep; 103(9):1692-1708. PubMed ID: 32278626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The views and experiences of nurses and midwives in the provision and management of provider-initiated HIV testing and counseling: a systematic review of qualitative evidence.
    Evans C; Nalubega S; McLuskey J; Darlington N; Croston M; Bath-Hextall F
    JBI Database System Rev Implement Rep; 2016 Jan; 13(12):130-286. PubMed ID: 26767819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
    Hermel DJ; McKinnon WC; Wood ME; Greenblatt MS
    Fam Cancer; 2017 Jan; 16(1):159-166. PubMed ID: 27401692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.